Condition
MASH With Fibrosis clinical trials and research
As of November 12, 2026, Find a Trial lists 4 MASH With Fibrosis clinical trials that are recruiting, at sites in 24 countries (most in United Kingdom (2), France (2), Germany (2)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 24Countries
Newest MASH With Fibrosis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Does fructose worsen metabolism and liver inflammation in people with MASH? | — | London and 1 other locations | Recruiting | Jun 10, 2025 |
| Digoxin for NASH with stage 2–3 fibrosis | Phase 2 | New Haven, Connecticut and 1 other locations | Recruiting | Sep 19, 2024 |
| Evaluating efruxifermin for treating NASH/MASH with fibrosis | Phase 3 | Birmingham, Alabama and 360 other locations | Recruiting | Jan 22, 2024 |
| Screening patients at risk for liver disease in Europe | — | Brussels, Vlaams-brabant and 12 other locations | Recruiting | Dec 15, 2022 |
All recruiting trials (4)
-
Does fructose worsen metabolism and liver inflammation in people with MASH?
This test looks at whether short-term dietary fructose changes metabolism and increases liver inflammation in people aged 45–65 with MASH, people with simple fatty liver (steatosis), and healthy controls.
-
Digoxin for NASH with stage 2–3 fibrosis
This trial will see if taking once-daily digoxin helps clear NASH and reduce liver scarring in adults with biopsy-confirmed NASH and stage 2–3 fibrosis.
-
Evaluating efruxifermin for treating NASH/MASH with fibrosis
This study is testing a new medication called efruxifermin to see if it can help people with NASH or MASH and liver fibrosis feel better compared to a placebo.
-
Screening patients at risk for liver disease in Europe
This study is trying to find out if screening high-risk patients in Europe for liver disease using simple tests can help doctors identify and better understand conditions like metabolic dysfunction-associated steatotic liver disease.
Related topics
Quick answers
How many MASH With Fibrosis clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 24 countries. The most sites are in United Kingdom (2 trials), France (2 trials), Germany (2 trials), Italy (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.